MTHFR and neoplasm: Hazard ratio (HR) and 95% confidence interval (95% CI) for 5-yeras disease free survival (DFS) and overall survival (OS) in the pooled group of patients according to an increasing number of clinical (gender, tumor site and stage) and genetic (MTHFR-rs1801131, IFNG-rs1861494) risk factors.